American Chemie-Pharma, Inc. Austin, TX - 78750

American Chemie-Pharma, Inc. is categorized under Industrial Chemicals in Austin, TX and active since 1991.

American Chemie-Pharma, Inc. was established in 1991, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Industrial Chemicals business, which does work in the B2B market, and is classified as a Industrial Chemicals, under code number by the NAICS.

If you are seeking more information, feel free to contact at the company’s headquarters by writing to 13706 Research Blvd.
Summit Executive Center, Suite 302, Austin, Texas TX 78750 or by phoning (512) 219-7400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: American Chemie-Pharma, Inc.
Address: 13706 Research Blvd.
Summit Executive Center, Suite 302, Austin, Texas 78750
Phone Number: (512) 219-7400
Website Address: americanchemie.com
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 1991
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Industrial Chemicals
Share This Business:

American Chemie-Pharma, Inc. was started in 1991 to provide professional Industrial Chemicals under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact for inquiries that concern American Chemie-Pharma, Inc. by calling the company number (512) 219-7400, as your correspondence is most welcome. Additionally, the physical location of the headquarters of American Chemie-Pharma, Inc. can be found at the coordinates 30.45622,-97.79525 as well as the street address 13706 Research Blvd.
Summit Executive Center, Suite 302
in Austin, Texas 78750.

For its online presence, you may visit American Chemie-Pharma, Inc.’s website at americanchemie.com and engage with its social media outlets through on Twitter and on Facebook.